ProPublica

Journalism in the Public Interest

Cancel

UCB

UCB is a drug company based in Brussels, Belgium. Its U.S. subsidiary agreed to plead guilty in June 2011 and pay more than $34 million related to allegations that it promoted its epilepsy drug Keppra for unapproved uses.

UCB began reporting payments on food, gifts, consulting payments, travel, speaking fees and other similar exchanges as of January 2012. UCB combines all categories into a single amount.

UCB's 2013 U.S. sales: $2 billion. Source: IMS Health.

See all UCB payments, or visit UCB's transparency page.

Notable drugs

Payment Reports

2012 Jan. to Dec.

Avg. Quarterly Total
Combination $7,520,911 $30,083,643
$7,520,911 $30,083,643

2013 Jan. to Dec.

Avg. Quarterly Total
Combination $6,593,208 $26,372,832
$6,593,208 $26,372,832

Total Payments by State

State Total
Texas $6,240,973
California $6,175,215
New York $5,597,353
Florida $4,611,113
North Carolina $4,160,724
Pennsylvania $2,194,078
Ohio $1,826,818
Arizona $1,664,371
Michigan $1,474,741
Georgia $1,440,882
Illinois $1,305,709
New Jersey $1,270,979
Maryland $1,220,037
Tennessee $1,195,858
Colorado $1,028,033
Arkansas $994,904
Massachusetts $978,127
Alabama $946,722
Oklahoma $946,479
Missouri $897,751
Kentucky $885,448
Washington $840,072
Virginia $710,278
Connecticut $670,332
Louisiana $656,402
Minnesota $636,569
Wisconsin $609,888
Nebraska $604,413
Idaho $515,279
Indiana $480,436
West Virginia $454,023
South Carolina $452,829
Nevada $436,081
Utah $281,462
Iowa $253,358
Oregon $251,160
Kansas $245,615
District of Columbia $230,625
New Hampshire $208,020
Mississippi $207,088
Rhode Island $173,511
New Mexico $147,900
Puerto Rico $90,907
Vermont $49,791
Hawaii $40,043
South Dakota $36,335
Delaware $34,876
Montana $34,832
Maine $30,772
North Dakota $9,739
Wyoming $4,070
Alaska $3,347
[Unknown State] $108